Automation index

How much of a Winemaker’s job can AI already do?

A lab panel and a batch come earlier. Tasting, blending and signing the vintage do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

25%

AI can already do 25% of this job.

#228 / 643

Winemaker

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Lab work, densities and fermentation control. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Tasting, blending and the call on the vintage. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Vineyard, ripeness and when to pick. Estimate No public source provides a precise figure. This is our estimate.	18%	22%	+4
Ageing, barrel, filtration and bottling. Estimate No public source provides a precise figure. This is our estimate.	16%	32%	+5.1
Cellar, records and the board’s visit. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Signing the vintage and owning the bottle. Estimate No public source provides a precise figure. This is our estimate.	16%	14%	+2.2
Total	100%		25%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

27%

#153 / 643

Hospital pharmacist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Transcription, reconciliation and the error. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Validate, the interaction and the one that cannot. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Chemo, the cabinet and not mixing the batch. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Ward, the doubt and going down to see the patient. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The board, the expensive drug and not yielding to pressure. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Validate the regimen, and not missing the error. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low